We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sandoz Group Ag | LSE:0SAN | London | Ordinary Share | CH1243598427 | SANDOZ GROUP ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
17:35:56 | O | 204 | 32.1953 | CHF |
Date | Time | Source | Headline |
---|---|---|---|
07/5/2024 | 06:00 | UKREG | Sandoz reports first quarter 2024 sales |
30/4/2024 | 11:25 | UKREG | Shareholders approve all resolutions proposed by Board of Directors at.. |
30/4/2024 | 06:00 | UKREG | Sandoz reaches agreement with Amgen resolving all patent litigation related.. |
22/4/2024 | 06:00 | UKREG | Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab),.. |
21/3/2024 | 13:00 | UKREG | Sandoz opens new antibiotic production facility in Austria, to.. |
13/3/2024 | 06:00 | UKREG | Sandoz reports fourth quarter 2023 sales and full-year 2023 results |
05/3/2024 | 18:24 | UKREG | Sandoz receives FDA approval for first and only denosumab biosimilars |
05/3/2024 | 06:00 | UKREG | Sandoz announces nominations to the Board of Directors and leadership.. |
04/3/2024 | 06:00 | UKREG | Sandoz acquires CIMERLI® business from Coherus, further building biosimilar.. |
29/2/2024 | 06:00 | UKREG | Sandoz US subsidiaries resolve generic drug antitrust class action.. |
Sandoz (0SAN) Share Charts1 Year Sandoz Chart |
|
1 Month Sandoz Chart |
Intraday Sandoz Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions